Proteus 2.0: more edible monitoring

From what only 2.5 years ago wags dubbed ‘creepy’ pills and now is the accepted Proteus Digital Health pill/transmitter/smartphone model, there had to be more in the same vein–or alimentary canal. Teams at Carnegie Mellon University in Pittsburgh are working on digestible devices which have flexible polymer electrodes and are powered by a sodium ion electrochemical cell, to scrutinize for biomarkers or gastric problems. According to the CMU release, “The battery also could be used to stimulate damaged tissue or help in targeted drug delivery for certain types of cancer.” Health tech monitoring mavens may want to be in touch with… Carnegie Mellon’s Christopher Bettinger Develops Edible Electronics for Medical Device Industry